R Bruce Diebold

This inventor holds 24 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Forma Therapeutics, Inc., Forma Tm2, Inc., Genosco. Active years: 2017-2025.

USPTO Granted Patents = 24 (Patent Applications = 10)

% Patents Active = 50.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 10.3

ph-index = 13

Forward Citations = 316(Granted Patents)

Company Filing History:

17 out of 125

Forma Therapeutics, Inc.

Valo Early Discovery, Inc.

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Mutant-Isocitrate Dehydrogenase

Quinolinone Derivatives

Ubiquitin-Specific Protease

Pyridin-2(1H)-one

Protein Kinases

Pyrrolo

Pyrazolopyrimidines

Fused-Bicyclic Aryl

Phenyl Quinolinone

Pyrimidines Compositions

Heterocyclic Compounds

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2025-04-14),

2. 12064426 - Selective inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof (2024-08-20),

3. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors (2024-06-25),

4. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2022-11-15),

5. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors (2021-03-02),

6. 10889567 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2021-01-12),

7. 10807976 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors (2020-10-20),

8. 10577329 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2020-03-03),

9. 10550099 - Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors (2020-02-04),

10. 10550098 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2020-02-04),

11. 10414752 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2019-09-17),

12. 10407419 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors (2019-09-10),

13. 10377760 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors (2019-08-13),

14. 10294206 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2019-05-21),

15. 10280150 - Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors (2019-05-07),

Title: The Innovative Journey of R Bruce Diebold

Introduction: R Bruce Diebold is a distinguished inventor based in Waltham, MA, known for his groundbreaking contributions to various fields.

Latest Patents: R Bruce Diebold holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning several decades, R Bruce Diebold has established himself as a visionary inventor with a keen eye for identifying and solving complex problems through inventive solutions.

Collaborations: Throughout his career, R Bruce Diebold has collaborated with leading experts in the industry, further enhancing his innovative projects and bringing his ideas to life.

Conclusion: R Bruce Diebold's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a prominent inventor in Waltham, MA, inspiring future generations to push the boundaries of what is possible.